Clinical Trial Update: Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concomitant administration of Gardasil with a combined diphtheria, tetanus, pertussis and poliomyelitis vaccine in adolescents; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (Diphtheria, Tetanus, Pertussis, and Poliovirus vaccine)
• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Glandular and Epithelial, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2010-02-11